Related Experiment Video

Updated: May 15, 2026

Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry
08:23

Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry

Published on: November 5, 2019

Potential role for statins in sickle cell disease

Soheir S Adam1, Carolyn Hoppe

  • 1Division of Hematology/Oncology, Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA. soheir.adam@duke.edu

Pediatric Blood & Cancer
|January 3, 2013
PubMed

Insights

Statins, used for cardiovascular disease, may benefit sickle cell disease (SCD) patients. Their anti-inflammatory and vascular effects show potential beyond cholesterol reduction for SCD management.

Area of Science:

  • Vascular Biology
  • Pharmacology
  • Hematology

Background:

  • Sickle cell disease (SCD) involves complex pathophysiology similar to chronic vascular diseases, driven by ischemia reperfusion, coagulation, and inflammation.
  • Statins are widely used for cardiovascular disease prevention due to their lipid-lowering properties.

Purpose of the Study:

  • To review the existing evidence on the potential therapeutic role of statins in managing sickle cell disease (SCD).

Main Methods:

  • Literature review of studies investigating statins and their effects on pathways relevant to SCD.
  • Analysis of pleiotropic effects of statins, including anti-inflammatory and endothelial function modulation.

Main Results:

  • Statins exhibit pleiotropic effects beyond lipid reduction.
  • These effects include down-regulation of inflammatory mediators, endothelial adhesion molecules, and tissue factor.
  • Statins may also restore nitric oxide bioavailability, a critical factor in vascular health.

Conclusions:

  • The pleiotropic effects of statins present them as promising therapeutic candidates for sickle cell disease.
  • Further research and clinical trials are warranted to establish the efficacy of statins in SCD treatment.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Multiple Allele Traits01:49

Multiple Allele Traits

The Concept of Multiple Allelism
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...